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Introduction
Shock is common in the intensive care units (ICUs) and
is treated with fluids and vasoactive drugs. In 2003 a
Scandinavian practice survey was performed document-
ing an extensive use of colloids and dopamine (1). In the
last decade new research has questioned these practices
(2,3). Hemodynamic monitoring and evaluation is also
under debate.
Objectives
To identify current practice for the treatment of shock in
Nordic ICUs. Primary outcomes were the type of vaso-
pressor and/or inotropic (VP/I) drugs and resuscitation
fluids used. Secondary outcomes was the type of hemody-
namic monitoring used and desired target values.
Methods
An observational descriptive cross-sectional study in
intensive care units in Denmark, Finland, Norway and
Sweden. Patients were included if in shock and older than
14 years with at least 4 hours of continuous VP/I -drug
infusion during a 7-day inclusion period in July and
August 2014. Pre-specified subgroup analysis for patients
with sepsis and cardiac failure were performed.
Results
171 patients were included. Median Sequential Organ
Failure Assessment (SOFA) score was 8 and 80% were
mechanically ventilated. 82% had received VP/I-drug
therapy < 24h at inclusion. 84% received volume loading
before onset of VP/I-drug treatment. Ringer´s solution
was given in 90% of patients and starches in 3/143
patients. Hypotension was the most common indication
for VP/I-drug therapy (95%). Noradrenaline was the most
commonly used VP/I-drug, given in 98% of cases. 21%
received treatment with more than one VP/I drug.
Dopamine was used in 2/170 patients. 97% were moni-
tored with invasive arterial blood pressure. MAP,
followed by lactate and diuresis were considered the
most important variables for monitoring. The pulmonary
arterial catheter was used in 16%, arterial pulse wave ana-
lysis in 7% and echocardiography in 29%.
Conclusions
Significant changes in fluid and vasopressor use have
occurred within the last 10 years in Nordic ICUs. Ringer’s
solution and Noradrenaline are now used as first line
treatment in early shock and the use of starches and
dopamine is rare. Although most patients were moni-
tored with invasive arterial blood pressure, more compre-
hensive hemodynamic monitoring was surprisingly used
only in a minority of patients.
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